These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 20444651)

  • 1. Approaches to improve pain relief while minimizing opioid abuse liability.
    Webster LR; Fine PG
    J Pain; 2010 Jul; 11(7):602-11. PubMed ID: 20444651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal liability perspectives on abuse-deterrent opioids in the treatment of chronic pain.
    Brushwood DB; Rich BA; Coleman JJ; Bolen J; Wong W
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):333-48. PubMed ID: 21133741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on abuse-resistant and abuse-deterrent approaches to opioid formulations.
    Webster L
    Pain Med; 2009 Jul; 10 Suppl 2():S124-33. PubMed ID: 19691683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical strategies for the primary health care professional to minimize prescription opioid abuse.
    Gudin JA
    Postgrad Med; 2012 May; 124(3):131-8. PubMed ID: 22691907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamper-resistant opioid formulations in the treatment of acute pain.
    Passik SD
    Adv Ther; 2014 Mar; 31(3):264-75. PubMed ID: 24526323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain management in primary care: strategies to mitigate opioid misuse, abuse, and diversion.
    McCarberg BH
    Postgrad Med; 2011 Mar; 123(2):119-30. PubMed ID: 21474900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implications of tamper-resistant formulations for opioid rotation.
    Pappagallo M; Sokolowska M
    Postgrad Med; 2012 Sep; 124(5):101-9. PubMed ID: 23095430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing co-occurring substance use and pain disorders.
    Miotto K; Kaufman A; Kong A; Jun G; Schwartz J
    Psychiatr Clin North Am; 2012 Jun; 35(2):393-409. PubMed ID: 22640762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid abuse-deterrent strategies: role of clinicians in acute pain management.
    Webster LR; Brennan MJ; Kwong LM; Levandowski R; Gudin JA
    Postgrad Med; 2016 Jan; 128(1):76-84. PubMed ID: 26631936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond.
    Ruan X
    Expert Opin Pharmacother; 2011 May; 12(7):999-1001. PubMed ID: 21470064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuing evolution of opioid use in primary care practice: implications of emerging technologies.
    Stanos S
    Curr Med Res Opin; 2012 Sep; 28(9):1505-16. PubMed ID: 22937723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal precautions: it's not about the molecule!
    Gourlay DL; Heit HA
    J Pain; 2011 Jun; 12(6):722; author reply 723-4. PubMed ID: 21652004
    [No Abstract]   [Full Text] [Related]  

  • 17. Multimodal approaches to optimize outcomes of chronic opioid therapy in the management of chronic pain.
    Kirsh KL; Fishman SM
    Pain Med; 2011 Jan; 12 Suppl 1():S1-11. PubMed ID: 21226840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous opioid treatment for chronic noncancer pain: a time for moderation in prescribing.
    Colameco S; Coren JS; Ciervo CA
    Postgrad Med; 2009 Jul; 121(4):61-6. PubMed ID: 19641271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.
    Stanos S
    Phys Sportsmed; 2012 Nov; 40(4):12-20. PubMed ID: 23306411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on tamper-resistant drug formulations.
    Romach MK; Schoedel KA; Sellers EM
    Drug Alcohol Depend; 2013 Jun; 130(1-3):13-23. PubMed ID: 23415386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.